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ABSTRACT 
Purpose: The main purpose of this study was to assess the reliability of shape and 
heterogeneity features in both Positron Emission Tomography (PET) and low-dose 
Computed Tomography (CT) components of PET/CT. A secondary objective was to 
investigate the impact of image quantization. 
Material and methods: A Health Insurance Portability and Accountability Act -compliant 
secondary analysis of deidentified prospectively acquired PET/CT test-retest datasets 
of 74 patients from multi-center Merck and ACRIN trials was performed. Metabolically 
active volumes were automatically delineated on PET with Fuzzy Locally Adaptive 
Bayesian algorithm. 3DSlicerTM was used to semi-automatically delineate the 
anatomical volumes on low-dose CT components. Two quantization methods were 
considered: a quantization into a set number of bins (quantizationB) and an alternative 
quantization with bins of fixed width (quantizationW). Four shape descriptors, ten first-
order metrics and 26 textural features were computed. Bland-Altman analysis was 
used to quantify repeatability. Features were subsequently categorized as very 
reliable, reliable, moderately reliable and poorly reliable with respect to the 
corresponding volume variability.  
Results: Repeatability was highly variable amongst features. Numerous metrics were 
identified as poorly or moderately reliable. Others were (very) reliable in both 
modalities, and in all categories (shape, 1st-, 2nd- and 3rd-order metrics). Image 
quantization played a major role in the features repeatability. Features were more 
reliable in PET with quantizationB, whereas quantizationW showed better results in CT. 
Conclusion:  The test-retest repeatability of shape and heterogeneity features in PET 
and low-dose CT varied greatly amongst metrics. The level of repeatability also 
depended strongly on the quantization step, with different optimal choices for each 
modality. The repeatability of PET and low-dose CT features should be carefully taken 
into account when selecting metrics to build multiparametric models. 
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INTRODUCTION 
The crucial role of positron emission tomography/computed tomography (PET/CT) with 
fluorine-18 fluorodeoxyglucose (FDG) for diagnosis and staging of non-small cell lung 
cancer (NSCLC) is established (1). Tumor metabolism is usually quantified with 
standardized uptake value (SUV) metrics (e.g., maximum and mean) in PET, whereas 
the low-dose CT component’s role is limited to PET attenuation correction and 
anatomical localization.  
Radiomics denotes the extraction of intensity, shape and heterogeneity features from 
medical images (2). Its application to PET (3) and CT (4) has gained interest for 
characterizing NSCLC tumors quantitatively, with potentially higher value than 
standard metrics, with the opportunity to combine features from both PET and low-
dose CT components (5). 
A first challenge is that numerous features can be calculated, most of which are 
sensitive to image noise, segmentation or reconstruction settings (7–11). Their use for 
therapy response monitoring and early prediction faces another challenge: 
repeatability. Because metrics calculated in pre-, mid- and post-therapy images need 
to be compared, test-retest repeatability allows determining the cut-off above which a 
change is attributed to response or progression. This has been estimated at ±15% to 
30% for SUV and volume (12,13). Regarding shape and heterogeneity metrics, several 
studies have investigated their repeatability in PET with FDG or fluorine-18 
fluorothymidine  (8,14–17) and in diagnostic CT (18,19), dosimetry CT (4,18), contrast-
enhanced CT (CE-CT) (18,20) or cone-beam CT (CBCT) (21). These studies exploited 
small single-center cohorts [n=8 CE-CT (20), n=10 CBCT (21), n=11 FDG-PET 
(8,15,17), n=11 fluorine-18 fluorothymidine-PET (16), n=16 FDG-PET (14), n=20 CT 
and 13 CE-CT (18) and n=31 CT (4,19)] and never reported on the repeatability of 
features from the low-dose CT from PET/CT, which is important when combining 
features from both components (5). 
Finally, it has been shown recently that the image quantization step in the 
calculation of textural features can have an impact on the relationship to other 
parameters (3) and on the repeatability (17,22). 
The primary goal of the present work was to evaluate the repeatability of shape 
and heterogeneity metrics from both PET and low-dose CT components in a large 
prospective multi-center cohort. A secondary goal was to evaluate the impact of the 
quantization step. 
MATERIALS AND METHODS 
Patient cohort and imaging 
Patients with stage IIIB-IV NSCLC were prospectively included in the multi-
center Merck MK-0646-008 (40 patients in 17 sites) and American College of 
Radiology Imaging Network (ACRIN) 6678 (34 patients in 14 sites) trials 
(NCT00424138 and NCT00729742, respectively) (23). Centers had to conform to the 
criteria of ACRIN PET qualification (www.acrin.org/6678_protocol.aspx) to participate. 
Merck used a similar accreditation program. PET/CT protocols were designed in 
accordance with National Cancer Institute guidelines (24). The institutional review 
board of each participating site approved the study, and all subjects signed a written 
informed consent form. The whole cohort of 74 patients has been previously included 
in (23), but only SUV measurements were analyzed whereas in this present analysis, 
texture features and shape parameters were also computed both on PET and CT 
images. The present secondary analysis of deidentified PET/CT images from these 
trials was approved by ACRIN and was performed in compliance with the Health 
Insurance Portability and Accountability Act. 
PET and CT analysis 
In both test-retest datasets, the PET and the low-dose CT images were 
processed independently. In PET, the metabolically active volumes (MAV) of the 
primary tumor and up to three additional lesions were segmented with the Fuzzy 
Locally Adaptive Bayesian algorithm previously validated for accuracy and robustness 
(25,26). In low-dose CT, the anatomical volume (AV) of primary tumors were 
delineated with a validated semi-automatic approach using 3D SlicerTM (27). Additional 
lesions were analyzed if they could be reliably delineated.  
The following metrics were calculated on the delineated volumes. Table 1 
contains a glossary. All features are described with their calculation formulae (3) in the 
Supplemental Material. 
3D shape descriptors were included, such as sphericity, irregularity or major 
axis (4,28). 
1st-order metrics (not accounting for spatial distribution of voxels) in both 
Hounsfield units (low-dose CT) and SUV (PET) include maximum and mean values, 
as well as histogram-derived skewness, kurtosis, energy, entropyHIST or the area under 
the curve of the cumulative histogram (CHAUC) (29). These metrics do not require 
quantization as a prior step. Quantization (not to be confused with quantification) is an 
intensity resampling step applied to the image prior to building textures matrices on 
which 2nd and 3rd order features rely. These matrices dimensions are determined by 
the number of intensity values obtained after this resampling. Several different 
quantization approaches have been proposed (3). 
2nd-order metrics from grey-level co-occurrence matrix (GLCM) and 
neighborhood grey-tone difference matrix (NGTDM), and 3rd-order metrics from grey-
level zone size matrix  were calculated in a single matrix considering all 13 orientations 
simultaneously (30,31). Quantization was performed in a set number of bins B 
(denoted from here onwards quantizationB), as previously recommended (14,18,30,32) 
using equation 1: 
𝐼𝐵 = 𝐵 ×
𝐼 − 𝐼𝑚𝑖𝑛
𝐼𝑚𝑎𝑥 − 𝐼𝑚𝑖𝑛 
(1) 
Where Imax and Imin denote maximum and minimum intensity (Hounsfield units in low-
dose CT and SUV in PET), and B is the number of bins (here B=64). Choosing a 
different B value can have an impact on the repeatability of features (14). Results 
obtained with B=8 to 128 are in the Supplemental Material. It has been suggested that 
an alternative quantization using fixed-width bins (e.g., 0.5 SUV) can have an important 
impact (17,22). Results using this approach (denoted from here onwards 
quantizationw) following equation 2 were also generated. 
𝐼𝑊 = ⌈
𝐼𝑂
𝑊
⌉ − min (⌈
𝐼𝑂
𝑊
⌉) + 1 (2) 
Where W is the bin width (here 0.5 SUV for PET (22) and 10 Hounsfield units for low-
dose CT). Note that W=0.25 SUV and W=5 Hounsfield units were also tested but no 
significant differences were observed. Supplemental Figure 1 shows a NSCLC tumor 
with both PET and low-dose CT, and the corresponding quantization results and 
histograms.  
Statistical analysis 
Statistical analyses were performed with MedCalcTM (MedCalc Software, 
Belgium). The repeatability of each metric was assessed with Bland-Altman analysis 
by reporting the mean and standard deviation (SD) of the differences between the two 
measurements. Lower and upper repeatability limits were calculated as ±1.96×SD after 
log-transformation when not normal. Bland-Altman analysis was preferred over intra-
class correlation coefficients based on previous recommendations (33). Intra-class 
correlation coefficients are nonetheless provided in the Supplemental Material.  
Correlations between metrics were assessed with Spearman rank coefficients (rs). 
Each metric was also categorized with respect to the repeatability (SD) of the 
corresponding volume of interest (VOIrepSD): very reliable (≤0.5×VOIrepSD), reliable 
(>0.5×VOIrepSD and ≤1.5×VOIrepSD), moderately reliable (>1.5×VOIrepSD and 
≤2×VOIrepSD) and poorly reliable (>2×VOIrepSD). 
 
RESULTS 
The analysis was performed in 73 datasets because one was not available. In 
the PET images, 73 primary tumors and 32 additional lesions (nodal or distant 
metastases) were analyzed. Mean MAV was 47.8 cm3 (median 24.9 cm3, SD 55.4 
cm3). In the low-dose CT, 2 patients were excluded because visual assessment of 
images indicated that repeatable volume delineation could not be ensured 
(Supplemental Fig. 2). Seventy-one primary tumors and 5 additional lesions were 
analyzed. Mean AV was 52.4 cm3 (median 37.5 cm3, SD 53.0 cm3). . 
Figure 1 displays repeatability results of volume determination in both 
modalities, while Figures 2, 3 and 4 display repeatability of 1st-order metrics and shape 
descriptors, 2nd- and 3rd-order textural features, respectively. Tables containing all 
results with also other quantization values are in the Supplemental Material. 
PET and low-dose CT volumes 
As shown in Figure 1, MAV determination had a repeatability of -1.4±11.1%, 
with upper and lower repeatability limits of +20.3% and -23.2%, which was dependent 
on MAV, smaller volumes exhibiting significantly (rs=-0.41, p<0.0001) poorer 
repeatability. The AV determination had a similar repeatability of -0.4±10.5%, with 
upper and lower repeatability limits of +20.3% and -21.0%. Repeatability was less 
dependent on volume (rs=-0.32, p=0.006).  
PET (respectively low-dose CT) features were thus categorized with similar 
thresholds for reliability: ≤5.6% (respectively 5.3%), >5.6% (respectively 5.3%) and 
≤16.7% (respectively 15.8%), >16.7% (respectively 15.8%) and ≤22.2% (respectively 
21%) and >22.2% (respectively 21.0%). 
PET features 
Shape descriptors and 1st-order metrics 
Overall, the shape features in PET were very repeatable (Fig. 2). Irregularity 
and sphericity were very reliable, with only 4.8% SD. 3D surface and major axis were 
reliable although with higher variability (9.0% and 8.4%, respectively). Amongst 
intensity-based 1st-order features, the most repeatable were CHAUC (-0.2 ± 3.6%) and 
entropyHIST (-0.2 ± 3.6%), whereas the least repeatable were energy (-1.2 ± 23.8%) 
and skewness (-1.1 ± 33.7%). Mean (SUVmean) and max (SUVmax) values were 
moderately reliable, with upper and lower repeatability limits of -30.4% and 36.3%, and 
-34.3% and 41.3%, respectively. 
2nd-order metrics 
As shown in Figure 3, with quantizationB, amongst GLCM features, entropyGLCM 
(-0.1 ± 2.6%), sum entropy (-0.2 ± 2.1%) and difference entropy (-0.2 ± 3.0%) were the 
most repeatable, whereas most other features fell in the reliable category. Five were 
categorized as moderately reliable and 3 as unreliable. For correlation the very poor 
repeatability is due to a few outliers for values around zero, to which Bland-Altman is 
very sensitive. After excluding them, correlation had reproducibility limits below ±20% 
and could be re-categorized as moderately reliable. The five NGTDM features were 
less repeatable than the best GLCM features although still categorized as reliable, all 
achieving SD ~14-17%, except contrastNGTDM (27.6%).  
The use of the alternate quantizationW changed both the above hierarchy and 
the absolute repeatability of the features. Overall, features calculated after 
quantizationW were much less reliable with notably more outliers, all exhibiting a higher 
variability than MAV. 
3nd-order metrics 
As shown in figure 4, amongst 3rd-order metrics, quantization had a similar 
impact: with quantizationW all grey-level zone size matrix features were categorized as 
poorly reliable, whereas with quantizationB two were very reliable (small zone size 
emphasis and zone size percentage with SD <4%) and 3 reliable (large zone size 
emphasis, gray-level non-uniformity and zone size non-uniformity with SD ~11-14%). 
Amongst the least repeatable features were those focusing on small zones and/or low 
grey values (e.g., LZLGE, SZLGE and LGLZE). 
Low-dose CT features  
Shape descriptors and 1st-order metrics 
As shown in Figure 2, morphological irregularity, sphericity and 3D surface were 
the most repeatable (SD 3.3%, 10.0% and 11.6%, respectively). Major axis was less 
reliable (3.8 ± 18.4%). 
On the one hand, four histogram metrics showed poor reliability such as maximum (4.7 
± 38.6%) and mean (-4.2 ± 43.6%) intensity, kurtosis (4.8 ± 37.4%) and skewness 
(11.1 ± 202.2%). On the other hand, entropyHIST and CHAUC were very reliable (-0.1 ± 
2.5% and 0.7 ± 9.1%). 
2nd-order metrics 
The repeatability depended strongly on the quantization, quantizationw 
improving the repeatability compared to quantizationB (Fig. 3). Amongst GLCM metrics, 
the most repeatable (for quantizationB vs. quantizationw, respectively) were 
entropyGLCM (-1.9 ± 12.0% vs. -0.4 ± 5.2%), sum entropy (-1.4 ± 10.0% vs. 0.1 ± 0.4%) 
and difference entropy (-2.3 ± 13.1% vs. -0.3 ± 1.9%). To a lesser extent, the same 
was observed for NGTDM, with higher repeatability using quantizationw. Complexity 
was the only parameter with variability <15.8% and categorized as reliable (0.5 ± 
14.3% and -0.5 ± 12.3% with quantizationB and quantizationw, respectively). 
 3nd-order metrics 
The quantization method also had an important impact (Fig. 4). Eight 
parameters were categorized as moderately reliable or better with quantizationw and 
only two with quantizationB. Small zone size emphasis (-0.6 ± 4.8% vs. -0.5 ± 2.6% 
with quantizationB and quantizationw, respectively) and zone size emphasis (-2.8 ± 
17.4% vs. -0.9 ± 11.9%) were the most repeatable features (Figs. 4D and 4E). 
Impact of quantization method 
Overall, the inverted impacts of the quantization method observed in PET and 
low-dose CT can be explained by the different correlative relationships between the 
features and the corresponding volume and maximum intensity. In PET, we observed 
that quantizationW features were correlated with SUVmax and not with MAV. On the 
contrary, features calculated with quantizationB were correlated with MAV but not 
SUVmax. The higher repeatability obtained with quantizationB can thus be explained by 
the fact that MAV repeatability was much higher than that of SUVmax. Contrary to PET, 
features in low-dose CT were correlated with both volume and maximum intensity 
using quantizationB, whereas they were less or not correlated with either volume or 
intensity using quantizationW. Because maximum intensity had a much worse 
repeatability than volume in CT, quantizationB thus led to worse repeatability. This is 
illustrated in Figure 5 for the feature dissimilarity. Note the relative inversion of 
relationships with volume and SUVmax for quantizationB compared to quantizationW in 
the case of the PET component. On the contrary for the low-dose CT component, 
quantizationB led to a higher correlation with maximum intensity than volume, but 
quantizationW led to lower correlation with volume and non-significant correlation with 
maximum intensity. 
DISCUSSION 
In the present work, 73 test-retest PET/CT acquisitions from 31 centers (17 for 
ACRIN in the USA and 14 for Merck in Asia and Europe) were analyzed for 
repeatability.  
A similar variability of volume delineations was observed for both modalities. 
MAV from PET were slightly smaller than AV measured in CT, mostly due to the fact 
that more lymph nodes and metastases were delineated in PET than in CT, and some 
large CT volumes had parts without FDG uptake. Regarding SUVmean and SUVmax, our 
results differ slightly from those previously published in the same cohort (23). Only 
lesions with SUVmax>4 were included in the previous analysis, whereas we did not 
restrict it. By restricting to SUVmax>4, our test-retest results for SUVmax were similar to 
those previously reported. 
Regarding shape and heterogeneity features, our results confirm prior findings 
in PET (8,14–17). To the best of our knowledge, our study is the first to report on the 
repeatability of these features in the low-dose CT component. 
Overall, the geometric features (shape descriptors) were found reliable (some 
with high repeatability) in both modalities, which can be related to the high repeatability 
of segmentation. This is in line with previous findings for PET (8,17) and with 
morphological shape in other CT modalities (4). We emphasize that only one 
segmentation by one expert was considered. The variability might be higher when 
considering different segmentation approaches and/or several observers. 
Regarding 1st-order metrics and textural higher-order features, our results 
confirm that the repeatability varies greatly amongst metrics. On the one hand, several 
features were confirmed to be unreliable in both modalities and should be 
systematically avoided, e.g., 1st-order skewness, 2nd-order Angular Second Moment, 
contrastGLCM and contrastNGTDM, and 3rd-order metrics quantifying low grey values 
and/or small zones. On the other hand, it should be emphasized that several features 
were identified as reliable, in all three categories and for both modalities. In between, 
other features with moderate repeatability should be used with caution as they exhibit 
larger variability than the corresponding volume determination. 
We compared two different quantization methods. QuantizationB is most often 
used. The impact of choosing another B value has been evaluated previously (14) and 
our results confirm these findings. Although B=64 is a good compromise and most 
features exhibited similar repeatability with different values, repeatability of some 
metrics depended on B. We observed a different impact in PET and low-dose CT for 
quantizationW, as it led to worse repeatability in PET but better repeatability in low-
dose CT. This was explained by the different relationships between the features and 
the corresponding volume and maximum intensity. With more control over data 
acquisition and higher repeatability of SUVmax, quantizationW may lead to higher 
repeatability. These results highlight the major impact of the quantization step and its 
variable impact depending on image modality that should thus not be overlooked. 
Our results confirm that studies building clinical models by combining features 
from PET/CT images should carefully account for repeatability. This is mandatory 
when calculating evolution of features across pre-, mid- and/or post-therapy images. 
This is nonetheless an important factor when building models based on single time-
point images, as models built using robust and repeatable features are more likely to 
be generalizable and achieve good performance in external/testing cohorts. 
Repeatability is not the only criterion on which feature selection needs to be based, as 
discriminative power, robustness and redundancy have to be considered also. 
Our study has limitations. Low-dose CT and PET images were analyzed 
separately using different segmentation processes performed independently on the 
test and re-test images. The repeatability evaluation therefore includes the intrinsic 
repeatability of the segmentation. We used robust segmentation approaches that 
should minimize variability. Another approach would consist in defining the volume on 
the test image and register it on the re-test image, which however requires accurate 
registration and raises other issues (34). In a clinical environment, the use of less 
accurate and less robust segmentation could lead to a lower repeatability, especially 
for volume-correlated features. 
We chose to categorize the repeatability levels of each metric with respect to 
that of the corresponding volume. The repeatability acceptance was similar for both 
modalities (reliability in PET was defined as SD below 16.5%, compared to 15.8% for 
low-dose CT). These thresholds are arbitrary and choosing different values would 
change the categorization of several metrics, but without changing their hierarchy. 
Finally, respiratory gating was not applied. In NSCLC this may lead to different 
levels of quantitative bias between the test and retest images, as well as between PET 
and low-dose CT. The repeatability we reported are therefore larger than what could 
ideally be obtained in other body regions where motion is less important, or if 
respiratory motion correction was applied (35). 
CONCLUSION 
Test-retest repeatability of shape and heterogeneity features in both 
components of PET/CT varied greatly amongst metrics. The repeatability also 
depended on the quantization step, with different optimal choices for PET or low-dose 
CT, because of different relationships of the metrics with volume or intensity. The 
repeatability of PET/CT features should be carefully accounted for when choosing 
metrics to combine in multiparametric models.  
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Table 1. Glossary 
MAV Metabolically active volume (PET) 
AV Anatomical volume (low-dose CT) 
CHAUC Area Under the Curve of the Cumulative 
Histogram 
ASM Angular Secondary Moment 
IDM Inverse Different Moment 
ID Inverse Difference 
SOSV Sum Of Square Variance 
SAVE Sum AVErage 
SVAR Sum VARiance 
SENT Sum ENTropy 
DVAR Difference VARiance 
DENT Difference ENTropy 
IC Information Correlation 
TS Texture strength 
CP Cluster Prominence 
SZSE Small Zone Size Emphasis 
LZSE Large Zone Size Emphasis 
ZSNU Zone Size Non-Uniformity 
GLNU Gray-Level Non-Uniformity 
ZSP Zone Size Percentage 
LGLZE Low Grey Level Zone Emphasis 
HGLZE High Grey Level Zone Emphasis 
SZLGE Small Zone / Low Grey Emphasis 
SZHGE Small Zone / High Grey Emphasis 
LZLGE Large Zone / Low Grey Emphasis 
LZHGE Large Zone High Grey Emphasis 
  
FIGURE CAPTIONS 
Figure 1: Bland-Altman analysis and correlation between volume and repeatability for 
MAV and AV determination. 
Figure 2: Repeatability of 1st-order metrics and 3D shape descriptors measured on 
FDG PET (left) and low-dose CT (right). Features are ranked from highest (left) to 
lowest (right) repeatability. VR = very reliable ; R = reliable ; MR = moderately reliable 
; PR = poorly reliable. 
Figure 3: Repeatability of 2nd-order metrics measured on FDG PET (first row) and low-
dose CT (second row), using either quantizationB (first column) or quantizationW 
(second column). Features are ranked from highest (left) to lowest (right) repeatability. 
VR = very reliable ; R = reliable ; MR = moderately reliable ; PR = poorly reliable. 
Figure 4: Repeatability of 3rd-order metrics measured on FDG PET (first row) and low-
dose CT (second row), using either quantizationB (first column) or quantizationW 
(second column). Features are ranked from highest (left) to lowest (right) repeatability. 
VR = very reliable ; R = reliable ; MR = moderately reliable ; PR = poorly reliable. 
Figure 5: Illustration of correlative relationships between a textural feature 
(dissimilarity from GLCM) and volume (first row) or maximum intensity (second row), 
in both PET (first column) and low-dose CT (second column) components, depending 
on the quantization approach. 
 
 
